Cargando…
Modified protocol of omalizumab treatment to prevent carboplatin-induced drug hypersensitivity reactions: a case study
Carboplatin administration can usually be safely continued via a so-called desensitisation protocol when hypersensitivity reactions arise. Severe break-through reactions that occur early during desensitisation are likely to be IgE-mediated; in that case, addition of omalizumab premedication should b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990484/ https://www.ncbi.nlm.nih.gov/pubmed/32015827 http://dx.doi.org/10.1186/s13601-020-0309-0 |